Oral BPC-157 is usually taken once daily, while injections may be done once or twice a day, often near the injury site
However, for similar effects, people with type 2 diabetes may prefer Mounjaro, another within the tirzepatide category, approved for type 2 diabetes
The IGF-signalling system has long been an area of therapeutic interest in the treatment of breast cancer which was further supported by the findings of both the European Prospective Investigation into Cancer and Nutrition (Kaaks et al., 2014) and the Endogenous Hormones and Breast Cancer Collaborative group (Murphy et al., 2020)
Very large doses can result in lactic acidosis (a drop in pH of the blood) and coma (Ferner 2011
Treatment duration is typically indefinite unless contraindications develop, with periodic reassessment by a qualified provider